Pegoraro F, Papo M, Maniscalco V, Charlotte F, Haroche J, Vaglio A. Erdheim-Chester disease: a rapidly evolving disease model. Leukemia. 2020;34:2840–57.
Article CAS PubMed Google Scholar
Haroche J, Cohen-Aubart F, Amoura Z. Erdheim-Chester disease. Blood. 2020;135:1311–8.
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672–81.
Article CAS PubMed PubMed Central Google Scholar
Razanamahery J, Diamond EL, Cohen-Aubart F, Plate KH, Lourida G, Charlotte F, et al. Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1. Haematologica. 2020;105:e5–8.
Article PubMed PubMed Central Google Scholar
Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135:1929–45.
Article CAS PubMed Google Scholar
Cohen-Aubart F, Emile JF, Carrat F, Helias-Rodzewicz Z, Taly V, Charlotte F, et al. Phenotypes and survival in Erdheim-Chester disease: results from a 165-patient cohort. Am J Hematol. 2018;93:E114–7.
Chazal T, Pegoraro F, Manari G, Bettiol A, Maniscalco V, Gelain E, et al. Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis. Kidney Int. 2023;103:177–86.
Papo M, Razanamahéry J, Da Silva M, Hélias-Rodzewicz Z, Potapenko V, Bota S, et al. Clinical phenotype of adult-onset systemic histiocytosis harboring BRAF in-frame deletions. Haematologica. 2024;109:3048–52.
PubMed PubMed Central Google Scholar
Kemps PG, Picarsic J, Durham BH, Hélias-Rodzewicz Z, Hiemcke-Jiwa L, van den Bos C, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022;139:256–80.
Article CAS PubMed PubMed Central Google Scholar
Pegoraro F, Papo M, Cohen-Aubart F, Peyronel F, Lugli G, Trambusti I, et al. Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis). EClinicalMedicine. 2024;73:102658.
Article PubMed PubMed Central Google Scholar
Friedman JS, Durham BH, Reiner AS, Yabe M, Petrova-Drus K, Dogan A, et al. Mixed histiocytic neoplasms: a multicentre series revealing diverse somatic mutations and responses to targeted therapy. Br J Haematol. 2024;205:127–37.
Article CAS PubMed Google Scholar
McLachlan GJ. Cluster analysis and related techniques in medical research. Stat Methods Med Res. 1992;1:27–48.
Article CAS PubMed Google Scholar
van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J. The identification of Parkinson’s disease subtypes using cluster analysis: a systematic review. Mov Disord. 2010;25:969–78.
Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181:315–23.
Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J. 2010;36:531–9.
Husson F, Josse J. Multiple correspondence analysis. In: Visualization and verbalization of data. Chapman and Hall/CRC; 2014.
Josse J, Husson F. Selecting the number of components in principal component analysis using cross-validation approximations. Computational Stat Data Anal. 2012;56:1869–79.
Josse J, Chavent M, Liquet B, Husson F. Handling missing values with regularized iterative multiple correspondence analysis. J Classif. 2012;29:91–116.
Murtagh F, Legendre P. Ward’s hierarchical agglomerative clustering method: which algorithms implement Ward’s criterion?. J Classif. 2014;31:274–95.
Steinley D. K-means clustering: a half-century synthesis. Brit J Math Stat Psychol. 2006;59:1–34.
Hennig C. Cluster-wise assessment of cluster stability. Computational Stat Data Anal. 2007;52:258–71.
Lê S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25:1–18.
Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, et al. Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov. 2016;6:154–65.
Article CAS PubMed Google Scholar
Durham BH, Lopez Rodrigo E, Picarsic J, Abramson D, Rotemberg V, De Munck S, et al. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat Med. 2019;25:1839–42.
Article CAS PubMed PubMed Central Google Scholar
Berres ML, Lim KPH, Peters T, Price J, Takizawa H, Salmon H, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014;211:669–83.
Article CAS PubMed PubMed Central Google Scholar
Milne P, Bigley V, Bacon CM, Néel A, McGovern N, Bomken S, et al. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood. 2017;130:167–75.
Article CAS PubMed PubMed Central Google Scholar
Durham BH, Roos-Weil D, Baillou C, Cohen-Aubart F, Yoshimi A, Miyara M, et al. Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Blood. 2017;130:176–80.
Article CAS PubMed PubMed Central Google Scholar
Mass E, Jacome-Galarza CE, Blank T, Lazarov T, Durham BH, Ozkaya N, et al. A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease. Nature. 2017;549:389–93.
Article CAS PubMed PubMed Central Google Scholar
Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015;518:547–51.
Mass E, Ballesteros I, Farlik M, Halbritter F, Günther P, Crozet L, et al. Specification of tissue-resident macrophages during organogenesis. Science. 2016;353:aaf4238.
Comments (0)